2200002K05Rik Inhibitors
The class of 2200002K05Rik inhibitors comprises a diverse range of chemicals that target key signaling pathways and regulators involved in cellular processes associated with 2200002K05Rik. These inhibitors act on various molecular targets, including nuclear receptors, protein kinases, and signaling molecules.
PPAR agonists, such as GW7647 and GW501516, activate peroxisome proliferator-activated receptors (PPARs), influencing gene expression and cellular processes linked to 2200002K05Rik. AICAR and metformin activate AMP-activated protein kinase (AMPK), serving as energy sensors that can modulate cellular responses associated with 2200002K05Rik. Nuclear receptor agonists, including SR9009 and rosiglitazone, target Rev-Erbα and PPARγ, respectively, potentially influencing gene expression and metabolic pathways.
Inhibitors like fasudil and LY294002 target Rho kinase (ROCK) and phosphoinositide 3-kinase (PI3K), respectively, affecting cellular signaling pathways linked to 2200002K05Rik. Compounds such as PDGF and lithium chloride modulate receptor tyrosine kinases and glycogen synthase kinase-3 (GSK-3), impacting signaling cascades associated with 2200002K05Rik.
ICG-001 inhibits the interaction between CREB-binding protein (CBP) and β-catenin, affecting Wnt signaling, which is implicated in various cellular functions. Nicotinamide riboside influences cellular metabolism by regulating NAD+ levels, potentially impacting pathways associated with 2200002K05Rik.
The class of 2200002K05Rik inhibitors provides a versatile toolkit for investigating the regulatory mechanisms and functional roles of 2200002K05Rik in cellular processes. Understanding the interactions between these inhibitors and their specific molecular targets offers valuable insights into the complex signaling networks and pathways associated with 2200002K05Rik, contributing to a comprehensive understanding of its biological functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $49.00 $170.00 $267.00 $661.00 | 6 | |
GW7647 is a selective agonist for peroxisome proliferator-activated receptor delta (PPARδ). Activation of PPARδ by GW7647 may modulate downstream pathways associated with 2200002K05Rik, as PPARs play crucial roles in various cellular processes. | ||||||
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, also known as Cardarine, is a PPARδ agonist. Activation of PPARδ by GW501516 can influence gene expression and cellular processes associated with 2200002K05Rik, as PPARs are involved in the regulation of metabolism and inflammation. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMP-activated protein kinase (AMPK), which is a central regulator of cellular energy homeostasis. AMPK activation by AICAR may impact pathways linked to 2200002K05Rik, as AMPK regulates various cellular processes in response to energy status. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a PPARγ agonist, and PPARs are known to have overlapping functions. Activation of PPARγ by rosiglitazone may modulate cellular processes associated with 2200002K05Rik, as PPARs play roles in metabolism, inflammation, and cell differentiation. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMPK, a key cellular energy sensor. AMPK activation by metformin can modulate cellular processes associated with 2200002K05Rik, as AMPK regulates various pathways in response to energy status. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), impacting Wnt/β-catenin signaling. Inhibition of GSK-3 by lithium chloride may influence pathways linked to 2200002K05Rik, as Wnt signaling is involved in various cellular processes. | ||||||
Wnt Agonist | 853220-52-7 | sc-222416 sc-222416A | 5 mg 25 mg | $157.00 $609.00 | 23 | |
ICG-001 is a small molecule that inhibits CREB-binding protein (CBP)/β-catenin interaction, modulating Wnt signaling. Inhibition of CBP/β-catenin by ICG-001 may impact pathways associated with 2200002K05Rik, as Wnt signaling regulates cellular functions. | ||||||
Nicotinamide riboside | 1341-23-7 | sc-507345 | 10 mg | $411.00 | ||
Nicotinamide riboside is a precursor of nicotinamide adenine dinucleotide (NAD+), influencing cellular metabolism. Modulation of NAD+ levels by NR may impact pathways associated with 2200002K05Rik, as NAD+ is involved in various cellular processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor, affecting the PI3K/Akt signaling pathway. Inhibition of PI3K by LY294002 may influence pathways linked to 2200002K05Rik, as PI3K/Akt signaling regulates cell survival, growth, and metabolism. | ||||||